CRSP vs GPC · rev $11.6M vs P/E 21, rev $12.80B
Crispr Therapeutics AG (CRSP) versus Genuine Parts Co (GPC) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Genuine Parts Co (GPC) is a auto parts company listed on US.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported GPC revenue for 2026-06-30 was $12.80B. Net income was $416.1M. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
CRSP currently screens at market cap $5.42B. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Not investment advice. Open the CRSP and GPC stock pages for the full models.
Not investment advice.